Global Moist Wound Dressings Market Expected to Grow at 5.2% CAGR and Garner $6,807.2 Million in the 2022-2031 Timeframe [250-Pages] | Exclusive by Research Dive
30 janv. 2023 09h03 HE
|
Research Dive
New York, USA, Jan. 30, 2023 (GLOBE NEWSWIRE) -- According to the newly published Research Dive report, the global moist wound dressings market is anticipated to rise at a stable CAGR of 5.2%,...
ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development
12 janv. 2023 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (OTC Pink: VDRM) is pleased to announce that they have engaged the growth marketing services of INTENT SCIENCES who will help grow the...
NPWT Market: 8.8% CAGR for Negative Pressure Wound Therapy Market Worth $892Mn, Globally, by 2028: The Insight Partners
27 mai 2022 09h19 HE
|
The Insight Partners
New York, May 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Single-Use Negative Pressure Wound Therapy Devices Market Forecast to 2028 - COVID-19 Impact and...
Skin Grafting System Market Size Worth $1.34Bn, Globally, by 2028 at 7.1% CAGR - Exclusive Report by The Insight Partners
29 avr. 2022 06h16 HE
|
The Insight Partners
New York, April 29, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Skin Grafting System Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
RenovaCare Establishes Leadership Position in Cell Isolation and Spray Technology with Newly Awarded U.S. Patent
14 oct. 2021 08h30 HE
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., Oct. 14, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented cell therapy technologies for the regeneration of skin and tissues,...
ROSEN, A RESPECTED AND LEADING FIRM, Encourages PolarityTE, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – PTE
29 sept. 2021 16h08 HE
|
The Rosen Law Firm PA
NEW YORK, Sept. 29, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
RenovaCare Clinical Trial to Start at U.S. Burn Centers
07 juin 2021 08h30 HE
|
RenovaCare, Inc.
ROSELAND, N.J., June 07, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that it is initiating a clinical trial at four burn centers in the United...
RenovaCare to Present at H.C. Wainwright Global Life Sciences Conference March 9-10, 2021
25 févr. 2021 08h30 HE
|
RenovaCare, Inc.
ROSELAND, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook
22 déc. 2020 08h00 HE
|
RenovaCare, Inc.
ROSELAND, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones
19 nov. 2020 08h15 HE
|
RenovaCare, Inc.
ROSELAND, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...